HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 9 analysts with an average price target of $62.8. This is a potential upside of $6.86 (12.26%) from yesterday's end of day stock price of $55.94.

Halozyme Therapeutics's activity chart (see below) currently has 132 price targets and 139 ratings on display. The stock rating distribution of HALO is 90.63% BUY and 9.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.76% with an average time for these price targets to be met of 282.33 days.

Highest price target for HALO is $73, Lowest price target is $49, average price target is $62.8.

Most recent stock forecast was given by MOHIT BANSAL from WELLS FARGO on 13-Jan-2025. First documented stock forecast 11-Jun-2014.

Currently out of the existing stock ratings of HALO, 58 are a BUY (90.63%), 6 are a HOLD (9.38%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$57

$2.2 (4.01%)

$62

8 days ago
(13-Jan-2025)

4/7 (57.14%)

$3.95 (7.45%)

254

Hold

$53

$-1.8 (-3.28%)

$52

11 days ago
(10-Jan-2025)

14/15 (93.33%)

$-0.28 (-0.53%)

140

Buy

$70

$15.2 (27.74%)

$68

11 days ago
(10-Jan-2025)

13/29 (44.83%)

$16.72 (31.38%)

190

Buy

$73

$18.2 (33.21%)

$71

2 months 20 days ago
(01-Nov-2024)

6/12 (50%)

$15.85 (27.73%)

312

Buy

$57

$2.2 (4.01%)

$52

4 months 2 days ago
(19-Sep-2024)

6/6 (100%)

$-2.5 (-4.20%)

118

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 282.33 days on average for the stock forecasts to be realized with a an average price target met ratio 83.76

Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?

VIKRAM PUROHIT

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Vikram Purohit works at MORGAN STANLEY and has 1 price targets and 1 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Jason Butler with highest potential upside - $18.2

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with lowest potential downside - -$41.8

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?